Proteotoxicity: An underappreciated pathology in cardiac disease

Journal of Molecular and Cellular Cardiology

Volumn 71, Issue , 2014, Pages 3-10

  Sandri, Marco ^b,c,d   Robbins, Jeffrey ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b VENETIAN INSTITUTE OF MOLECULAR MEDICINE   (Italy)

^c CNR   (Italy)

^d UNIVERSITY OF PADOVA   (Italy)

Author keywords

Autophagy; Lysosome; Protein

Indexed keywords

PROTEASOME; UBIQUITIN;

AUTOPHAGY; CELL DEATH; HEART DISEASE; HEART FAILURE; HUMAN; INTRACELLULAR SIGNALING; LYSOSOME; MACROAUTOPHAGY; MITOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN HOMEOSTASIS; PROTEIN TARGETING; PROTEOTOXICITY; REVIEW; TOXICITY; ANIMAL; HOMEOSTASIS; METABOLISM; PATHOLOGY; PROTEIN SYNTHESIS; PROTEOSTASIS DEFICIENCY;

ANIMALIA;

ANIMALS; HEART DISEASES; HOMEOSTASIS; HUMANS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN BIOSYNTHESIS; PROTEIN FOLDING; PROTEOSTASIS DEFICIENCIES; UBIQUITIN;

EID: 84899920834     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2013.12.015     Document Type: Review

References (113)

1. Calamini B., Morimoto R.I. Protein homeostasis as a therapeutic target for diseases of protein conformation. Curr Top Med Chem 2012, 12:2623-2640.
2. Powers E.T., Balch W.E. Diversity in the origins of proteostasis networks-a driver for protein function in evolution. Nat Rev Mol Cell Biol 2013, 14:237-248.
3. Morimoto R.I. Proteotoxic stress and inducible chaperone networks in neurodegenerative disease and aging. Genes Dev 2008, 22:1427-1438.
4. Willis M.S., Patterson C. Proteotoxicity and cardiac dysfunction-Alzheimer's disease of the heart?. N Engl J Med 2013, 368:455-464.
5. Hightower L.E. Heat shock, stress proteins, chaperones, and proteotoxicity. Cell 1991, 66:191-197.
6. Akerfelt M., Morimoto R.I., Sistonen L. Heat shock factors: integrators of cell stress, development and lifespan. Nat Rev Mol Cell Biol 2010, 11:545-555.
7. Morimoto R.I. The heat shock response: systems biology of proteotoxic stress in aging and disease. Cold Spring Harb Symp Quant Biol 2011, 76:91-99.
8. Portbury A.L., Willis M.S., Patterson C. Tearin' up my heart: proteolysis in the cardiac sarcomere. J Biol Chem 2011, 286:9929-9934.
9. Kastle M., Grune T. Interactions of the proteasomal system with chaperones: protein triage and protein quality control. Prog Mol Biol Transl Sci 2012, 109:113-160.
10. Latonen L. Nucleolar aggresomes as counterparts of cytoplasmic aggresomes in proteotoxic stress. Proteasome inhibitors induce nuclear ribonucleoprotein inclusions that accumulate several key factors of neurodegenerative diseases and cancer. Bioessays 2011, 33:386-395.
11. Su H., Wang X. The ubiquitin-proteasome system in cardiac proteinopathy: a quality control perspective. Cardiovasc Res 2010, 85:253-262.
12. Verghese J., Abrams J., Wang Y., Morano K.A. Biology of the heat shock response and protein chaperones: budding yeast (Saccharomyces cerevisiae) as a model system. Microbiol Mol Biol Rev 2012, 76:115-158.
13. Ferreira P.A., Orry A. From Drosophila to humans: reflections on the roles of the prolyl isomerases and chaperones, cyclophilins, in cell function and disease. J Neurogenet 2012, 26:132-143.
14. Gaiser A.M., Kaiser C.J., Haslbeck V., Richter K. Downregulation of the Hsp90 system causes defects in muscle cells of Caenorhabditis elegans. PLoS One 2011, 6:e25485.
15. Epstein H.F., Benian G.M. Paradigm shifts in cardiovascular research from Caenorhabditis elegans muscle. Trends Cardiovasc Med 2012, 22:201-209.
16. Xu Q., Metzler B., Jahangiri M., Mandal K. Molecular chaperones and heat shock proteins in atherosclerosis. Am J Physiol Heart Circ Physiol 2012, 302:H506-H514.
17. Christians E.S., Ishiwata T., Benjamin I.J. Small heat shock proteins in redox metabolism: implications for cardiovascular diseases. Int J Biochem Cell Biol 2012, 44:1632-1645.
18. Iwaki T., Kume-Iwaki A., Liem R.K., Goldman J.E. Alpha B-crystallin is expressed in non-lenticular tissues and accumulates in Alexander's disease brain. Cell 1989, 57:71-78.
19. Bennardini F., Wrzosek A., Chiesi M. Alpha B-crystallin in cardiac tissue. Association with actin and desmin filaments. Circ Res 1992, 71:288-294.
20. He C., Klionsky D.J. Autophagy and neurodegeneration. ACS Chem Biol 2006, 1:211-213.
21. Roze E., Bonnet C., Betuing S., Caboche J. Huntington's disease. Adv Exp Med Biol 2010, 685:45-63.
22. Ebrahimi-Fakhari D., Wahlster L., McLean P.J. Protein degradation pathways in Parkinson's disease: curse or blessing. Acta Neuropathol 2012, 124:153-172.
23. Double K.L. Neuronal vulnerability in Parkinson's disease. Parkinsonism Relat Disord 2012, 18(Suppl. 1):S52-S54.
24. Safar J.G. Molecular pathogenesis of sporadic prion diseases in man. Prion 2012, 6:108-115.
25. Guest W.C., Silverman J.M., Pokrishevsky E., O'Neill M.A., Grad L.I., Cashman N.R. Generalization of the prion hypothesis to other neurodegenerative diseases: an imperfect fit. J Toxicol Environ Health A 2011, 74:1433-1459.
26. Crippa V., Sau D., Rusmini P., Boncoraglio A., Onesto E., Bolzoni E., et al. The small heat shock protein B8 (HspB8) promotes autophagic removal of misfolded proteins involved in amyotrophic lateral sclerosis (ALS). Hum Mol Genet 2010, 19:3440-3456.
27. Pattison J.S., Sanbe A., Maloyan A., Osinska H., Klevitsky R., Robbins J. Cardiomyocyte expression of a polyglutamine preamyloid oligomer causes heart failure. Circulation 2008, 117:2743-2751.
28. Wang X., Su H., Ranek M.J. Protein quality control and degradation in cardiomyocytes. J Mol Cell Cardiol 2008, 45:11-27.
29. Mearini G., Schlossarek S., Willis M.S., Carrier L. The ubiquitin-proteasome system in cardiac dysfunction. Biochim Biophys Acta 2008, 1782:749-763.
30. Willis M.S., Townley-Tilson W.H., Kang E.Y., Homeister J.W., Patterson C. Sent to destroy: the ubiquitin proteasome system regulates cell signaling and protein quality control in cardiovascular development and disease. Circ Res 2010, 106:463-478.
31. Sandri M. Protein breakdown in muscle wasting: role of autophagy-lysosome and ubiquitin-proteasome. Int J Biochem Cell Biol 2013, 45:2121-2129.
32. Sandri M. Protein breakdown in muscle wasting: Role of autophagy-lysosome and ubiquitin-proteasome. Int J Biochem Cell Biol 2013, 45:2121-2129.
33. Pagan J., Seto T., Pagano M., Cittadini A. Role of the ubiquitin proteasome system in the heart. Circ Res 2013, 112:1046-1058.
34. Calise J., Powell S.R. The ubiquitin proteasome system and myocardial ischemia. Am J Physiol Heart Circ Physiol 2013, 304:H337-H349.
35. Day S.M. The ubiquitin proteasome system in human cardiomyopathies and heart failure. Am J Physiol Heart Circ Physiol 2013, 304:H1283-H1293.
36. Lee D., Goldberg A. Atrogin1/MAFbx: what atrophy, hypertrophy, and cardiac failure have in common. Circ Res 2011, 109:123-126.
37. Bodine S.C., Latres E., Baumhueter S., Lai V.K., Nunez L., Clarke B.A., et al. Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 2001, 294:1704-1708.
38. Gomes M.D., Lecker S.H., Jagoe R.T., Navon A., Goldberg A.L. Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy. Proc Natl Acad Sci U S A 2001, 98:14440-14445.
39. Lecker S.H., Jagoe R.T., Gilbert A., Gomes M., Baracos V., Bailey J., et al. Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression. FASEB J 2004, 18:39-51.
40. Schiaffino S., Dyar K.A., Ciciliot S., Blaauw B., Sandri M. Mechanisms regulating skeletal muscle growth and atrophy. FEBS J 2013, 280:4294-4314.
41. Cai D., Frantz J.D., Tawa N.E., Melendez P.A., Oh B.C., Lidov H.G., et al. IKKbeta/NF-kappaB activation causes severe muscle wasting in mice. Cell 2004, 119:285-298.
42. Sartori R., Milan G., Patron M., Mammucari C., Blaauw B., Abraham R., et al. Smad2 and 3 transcription factors control muscle mass in adulthood. Am J Physiol Cell Physiol 2009, 296:C1248-C1257.
43. Sartori R., Schirwis E., Blaauw B., Bortolanza S., Zhao J., Enzo E., et al. BMP signaling controls muscle mass. Nat Genet 2013, 45:1309-1318.
44. Trendelenburg A.U., Meyer A., Rohner D., Boyle J., Hatakeyama S., Glass D.J. Myostatin reduces Akt/TORC1/p70S6K signaling, inhibiting myoblast differentiation and myotube size. Am J Physiol Cell Physiol 2009, 296:C1258-C1270.
45. Lokireddy S., Wijesoma I.W., Teng S., Bonala S., Gluckman P.D., McFarlane C., et al. The ubiquitin ligase Mul1 induces mitophagy in skeletal muscle in response to muscle-wasting stimuli. Cell Metab 2012, 16:613-624.
46. Nagpal P., Plant P.J., Correa J., Bain A., Takeda M., Kawabe H., et al. The ubiquitin ligase Nedd4-1 participates in denervation-induced skeletal muscle atrophy in mice. PLoS One 2012, 7:e46427.
47. Paul P.K., Gupta S.K., Bhatnagar S., Panguluri S.K., Darnay B.G., Choi Y., et al. Targeted ablation of TRAF6 inhibits skeletal muscle wasting in mice. J Cell Biol 2010, 191:1395-1411.
48. Shi J., Luo L., Eash J., Ibebunjo C., Glass D.J. The SCF-Fbxo40 complex induces IRS1 ubiquitination in skeletal muscle, limiting IGF1 signaling. Dev Cell 2011, 21:835-847.
49. Kaushik S., Cuervo A.M. Chaperones in autophagy. Pharmacol Res 2012, 66:484-493.
50. Kaushik S., Singh R., Cuervo A.M. Autophagic pathways and metabolic stress. Diabetes Obes Metab 2010, 12(Suppl. 2):4-14.
51. Rotter D., Rothermel B.A. Targets, trafficking, and timing of cardiac autophagy. Pharmacol Res 2012, 66:494-504.
52. Mijaljica D., Prescott M., Devenish R.J. Microautophagy in mammalian cells: revisiting a 40-year-old conundrum. Autophagy 2011, 7:673-682.
53. Tolkovsky A.M. Mitophagy. Biochim Biophys Acta 2009, 1793:1508-1515.
54. Arias E., Cuervo A.M. Chaperone-mediated autophagy in protein quality control. Curr Opin Cell Biol 2011, 23:184-189.
55. Hale A.N., Ledbetter D.J., Gawriluk T.R., Rucker E.B. Autophagy: regulation and role in development. Autophagy 2013, 9:951-972.
56. Chen Y., Klionsky D.J. The regulation of autophagy - unanswered questions. J Cell Sci 2011, 124:161-170.
57. Demontis F., Perrimon N. FOXO/4E-BP signaling in Drosophila muscles regulates organism-wide proteostasis during aging. Cell 2010, 143:813-825.
58. Mammucari C., Milan G., Romanello V., Masiero E., Rudolf R., Del Piccolo P., et al. FoxO3 controls autophagy in skeletal muscle in vivo. Cell Metab 2007, 6:458-471.
59. Mammucari C., Schiaffino S., Sandri M. Downstream of Akt: FoxO3 and mTOR in the regulation of autophagy in skeletal muscle. Autophagy 2008, 4:524-526.
60. Sandri M. FOXOphagy path to inducing stress resistance and cell survival. Nat Cell Biol 2012, 14:786-788.
61. Chen C.C., Jeon S.M., Bhaskar P.T., Nogueira V., Sundararajan D., Tonic I., et al. FOXOs inhibit mTORC1 and activate Akt by inducing the expression of Sestrin3 and Rictor. Dev Cell 2010, 18:592-604.
62. Lee J.H., Budanov A.V., Park E.J., Birse R., Kim T.E., Perkins G.A., et al. Sestrin as a feedback inhibitor of TOR that prevents age-related pathologies. Science 2010, 327:1223-1228.
63. Dunlop E.A., Hunt D.K., Acosta-Jaquez H.A., Fingar D.C., Tee A.R. ULK1 inhibits mTORC1 signaling, promotes multisite Raptor phosphorylation and hinders substrate binding. Autophagy 2011, 7:737-747.
64. Shaid S., Brandts C.H., Serve H., Dikic I. Ubiquitination and selective autophagy. Cell Death Differ 2013, 20:21-30.
65. Kirkin V., Lamark T., Sou Y.S., Bjorkoy G., Nunn J.L., Bruun J.A., et al. A role for NBR1 in autophagosomal degradation of ubiquitinated substrates. Mol Cell 2009, 33:505-516.
66. Pankiv S., Clausen T.H., Lamark T., Brech A., Bruun J.A., Outzen H., et al. p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. J Biol Chem 2007, 282:24131-24145.
67. McEwan D.G., Dikic I. The three musketeers of autophagy: phosphorylation, ubiquitylation and acetylation. Trends Cell Biol 2011, 21:195-201.
68. Lu H., Li G., Liu L., Feng L., Wang X., Jin H. Regulation and function of mitophagy in development and cancer. Autophagy 2013, 9.
69. Narendra D.P., Youle R.J. Targeting mitochondrial dysfunction: role for PINK1 and Parkin in mitochondrial quality control. Antioxid Redox Signal 2011, 14:1929-1938.
70. Youle R.J., Narendra D.P. Mechanisms of mitophagy. Nat Rev Mol Cell Biol 2011, 12:9-14.
71. Hanna R.A., Quinsay M.N., Orogo A.M., Giang K., Rikka S., Gustafsson A.B. Microtubule-associated protein 1 light chain 3 (LC3) interacts with Bnip3 to selectively remove endoplasmic reticulum and mitochondria via autophagy. J Biol Chem 2012, 287:19094-19104.
72. Novak I., Kirkin V., McEwan D.G., Zhang J., Wild P., Rozenknop A., et al. Nix is a selective autophagy receptor for mitochondrial clearance. EMBO Rep 2010, 11:45-51.
73. Gustafsson A.B., Gottlieb R.A. Autophagy in ischemic heart disease. Circ Res 2009, 104:150-158.
74. Rothermel B.A., Hill J.A. Autophagy in load-induced heart disease. Circ Res 2008, 103:1363-1369.
75. Komatsu M., Waguri S., Ueno T., Iwata J., Murata S., Tanida I., et al. Impairment of starvation-induced and constitutive autophagy in Atg7-deficient mice. J Cell Biol 2005, 169:425-434.
76. Hara T., Nakamura K., Matsui M., Yamamoto A., Nakahara Y., Suzuki-Migishima R., et al. Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature 2006, 441:885-889.
77. Nakai A., Yamaguchi O., Takeda T., Higuchi Y., Hikoso S., Taniike M., et al. The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress. Nat Med 2007, 13:619-624.
78. Taneike M., Yamaguchi O., Nakai A., Hikoso S., Takeda T., Mizote I., et al. Inhibition of autophagy in the heart induces age-related cardiomyopathy. Autophagy 2010, 6:600-606.
79. Cheng Z., Fang Q. Danon disease: focusing on heart. J Hum Genet 2012, 57:407-410.
80. Malicdan M.C., Nishino I. Autophagy in lysosomal myopathies. Brain Pathol 2012, 22:82-88.
81. Malicdan M.C., Noguchi S., Nonaka I., Saftig P., Nishino I. Lysosomal myopathies: an excessive build-up in autophagosomes is too much to handle. Neuromuscul Disord 2008, 18:521-529.
82. Ruivo R., Anne C., Sagne C., Gasnier B. Molecular and cellular basis of lysosomal transmembrane protein dysfunction. Biochim Biophys Acta 2009, 1793:636-649.
83. George K., Whyte G.P., Green D.J., Oxborough D., Shave R.E., Gaze D., et al. The endurance athletes heart: acute stress and chronic adaptation. Br J Sports Med 2012, 46(Suppl. 1):i29-i36.
84. Hein S., Arnon E., Kostin S., Schonburg M., Elsasser A., Polyakova V., et al. Progression from compensated hypertrophy to failure in the pressure-overloaded human heart: structural deterioration and compensatory mechanisms. Circulation 2003, 107:984-991.
85. Zhu H., Tannous P., Johnstone J.L., Kong Y., Shelton J.M., Richardson J.A., et al. Cardiac autophagy is a maladaptive response to hemodynamic stress. J Clin Invest 2007, 117:1782-1793.
86. Przyklenk K., Dong Y., Undyala V.V., Whittaker P. Autophagy as a therapeutic target for ischaemia/reperfusion injury? Concepts, controversies, and challenges. Cardiovasc Res 2012, 94:197-205.
87. Vicart P., Caron A., Guicheney P., Li Z., Prevost M.C., Faure A., et al. A missense mutation in the alphaB-crystallin chaperone gene causes a desmin-related myopathy. Nat Genet 1998, 20:92-95.
88. Sanbe A., Osinska H., Saffitz J.E., Glabe C.G., Kayed R., Maloyan A., et al. Desmin-related cardiomyopathy in transgenic mice: a cardiac amyloidosis. Proc Natl Acad Sci U S A 2004, 101:10132-10136.
89. Sanbe A., Osinska H., Villa C., Gulick J., Klevitsky R., Glabe C.G., et al. Reversal of amyloid-induced heart disease in desmin-related cardiomyopathy. Proc Natl Acad Sci U S A 2005, 102:13592-13597.
90. Wang X., Osinska H., Klevitsky R., Gerdes A.M., Nieman M., Lorenz J., et al. Expression of R120G-alphaB-crystallin causes aberrant desmin and alphaB-crystallin aggregation and cardiomyopathy in mice. Circ Res 2001, 89:84-91.
91. Pattison J.S., Osinska H., Robbins J. Atg7 induces basal autophagy and rescues autophagic deficiency in CryABR120G cardiomyocytes. Circ Res 2011, 109:151-160.
92. Maiuri M.C., Zalckvar E., Kimchi A., Kroemer G. Self-eating and self-killing: crosstalk between autophagy and apoptosis. Nat Rev Mol Cell Biol 2007, 8:741-752.
93. Noda N.N., Satoo K., Fujioka Y., Kumeta H., Ogura K., Nakatogawa H., et al. Structural basis of Atg8 activation by a homodimeric E1, Atg7. Mol Cell 2011, 44:462-475.
94. Bhuiyan M.S., Pattison J.S., Osinska H., James J., Gulick J., McLendon P.M., et al. Induced autophagy ameliorates cardiac proteinopathy. J Clin Invest 2013, 123:5284-5297.
95. Wang E.Y., Biala A.K., Gordon J.W., Kirshenbaum L.A. Autophagy in the heart: too much of a good thing?. J Cardiovasc Pharmacol 2012, 60:110-117.
96. Vikstrom K.L., Bohlmeyer T., Factor S.M., Leinwand L.A. Hypertrophy, pathology, and molecular markers of cardiac pathogenesis. Circ Res 1998, 82:773-778.
97. Baek K.H., Park J., Shin I. Autophagy-regulating small molecules and their therapeutic applications. Chem Soc Rev 2012, 41:3245-3263.
98. Bao X.H., Naomoto Y., Hao H.F., Watanabe N., Sakurama K., Noma K., et al. Autophagy: can it become a potential therapeutic target?. Int J Mol Med 2010, 25:493-503.
99. Dickey J.S., Rao V.A. Current and proposed biomarkers of anthracycline cardiotoxicity in cancer: emerging opportunities in oxidative damage and autophagy. Curr Mol Med 2012, 12:763-771.
100. Kimura T., Takabatake Y., Takahashi A., Isaka Y. Chloroquine in cancer therapy: a double-edged sword of autophagy. Cancer Res 2013, 73:3-7.
101. Yu L., Liu S. Autophagy contributes to modulating the cytotoxicities of Bcl-2 homology domain-3 mimetics. Semin Cancer Biol 2013, 23(6 Pt B):553-560.
102. Santulli G., Totary-Jain H. Tailoring mTOR-based therapy: molecular evidence and clinical challenges. Pharmacogenomics 2013, 14:1517-1526.
103. Cridge B.J., Rosengren R.J. Critical appraisal of the potential use of cannabinoids in cancer management. Cancer Manage Res 2013, 5:301-313.
104. Dimitrakis P., Romay-Ogando M.I., Timolati F., Suter T.M., Zuppinger C. Effects of doxorubicin cancer therapy on autophagy and the ubiquitin-proteasome system in long-term cultured adult rat cardiomyocytes. Cell Tissue Res 2012, 350:361-372.
105. Long L., Yang X., Southwood M., Lu J., Marciniak S.J., Dunmore B.J., et al. Chloroquine prevents progression of experimental pulmonary hypertension via inhibition of autophagy and lysosomal bone morphogenetic protein type II receptor degradation. Circ Res 2013, 112:1159-1170.
106. Cao D.J., Wang Z.V., Battiprolu P.K., Jiang N., Morales C.R., Kong Y., et al. Histone deacetylase (HDAC) inhibitors attenuate cardiac hypertrophy by suppressing autophagy. Proc Natl Acad Sci U S A 2011, 108:4123-4128.
107. Kong Y., Tannous P., Lu G., Berenji K., Rothermel B.A., Olson E.N., et al. Suppression of class I and II histone deacetylases blunts pressure-overload cardiac hypertrophy. Circulation 2006, 113:2579-2588.
108. Catoire H., Pasco M.Y., Abu-Baker A., Holbert S., Tourette C., Brais B., et al. Sirtuin inhibition protects from the polyalanine muscular dystrophy protein PABPN1. Hum Mol Genet 2008, 17:2108-2117.
109. Kimball S.R. Interaction between the AMP-activated protein kinase and mTOR signaling pathways. Med Sci Sports Exerc 2006, 38:1958-1964.
110. Marzetti E., Csiszar A., Dutta D., Balagopal G., Calvani R., Leeuwenburgh C. Role of mitochondrial dysfunction and altered autophagy in cardiovascular aging and disease: from mechanisms to therapeutics. Am J Physiol Heart Circ Physiol 2013, 305:H459-H476.
111. Sala-Mercado J.A., Wider J., Undyala V.V., Jahania S., Yoo W., Mentzer R.M., et al. Profound cardioprotection with chloramphenicol succinate in the swine model of myocardial ischemia-reperfusion injury. Circulation 2010, 122:S179-S184.
112. Gianni D., Li A., Tesco G., McKay K.M., Moore J., Raygor K., et al. Protein aggregates and novel presenilin gene variants in idiopathic dilated cardiomyopathy. Circulation 2010, 121:1216-1226.
113. Nemchenko A., Chiong M., Turer A., Lavandero S., Hill J.A. Autophagy as a therapeutic target in cardiovascular disease. J Mol Cell Cardiol 2011, 51:584-593.